Targeted cancer drug specialist Blueprint Medicines has agreed to pay $250 million upfront to acquire Lengo Therapeutics and its lead drug for lung cancer, a rival to already-approved therapies from ...

We may earn commission from links on this page, but we only recommend products we love. Promise. Listen, I’ll be the first person to tell you that homemade face masks can be a little questionable.

From volatility and geopolitics to economic trends and investment outlooks, stay informed on the key developments shaping today's markets. Whether it’s hardware, software or age-old businesses, ...